GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new ...
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...
Abstract: This communication proposes a dual-linear polarized 2-bit reconfigurable transmitarray (DLPRTA) operating at Ku-band. The independent dual-linear polarization unit cell consists of two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results